Test report DSG-8426 · Rev E · tested November 17, 2026
AI Datacenter InfrastructureDevice under test
Lumentum Trades 17.2% Below Marvell's $759.60 Buyout Offer
Lumentum trades at $648.06 against Marvell's implied $759.60 offer. A fixed 4.5-share ratio, a 2028 close and China approval risk explain the 17.2% merger arbitrage gap.
- Read
- 3 min
- Words
- 569
- Node
- 14nm
- Operator
- Grace Kim
Spec summary
- Marvell's 4.5-share all-stock offer implies $759.60 per Lumentum share at Marvell's $168.80 price, a 17.2% gap to Lumentum's $648.06.
- The deal, agreed November 2, 2026, isn't expected to close until H1 2028 and needs approvals including China's; a regulatory failure triggers a $3.2 billion fee.
- Lumentum's fiscal Q1 2027 revenue rose 136.5% year over year to $1.26 billion; non-GAAP gross margin hit 53.2%.
- Bernstein kept Outperform, cutting its target from $900 to $635 before raising it to $700.
- Since October 12, Marvell has fallen 38.7% and Lumentum 37.2% amid the AI hardware selloff.

Lumentum (NASDAQ:LITE) trades at $648.06 against a Marvell offer worth $759.60 per share, a gap of roughly 17.2%. Marvell's all-stock bid, struck November 2 at a fixed ratio of 4.5 Marvell (NASDAQ:MRVL) shares per Lumentum share, implied about $1,132 per Lumentum share at October 28 reference prices — a 23.9% premium. That was before the AI hardware selloff hit. Since October 12, Marvell has dropped 38.7% and Lumentum has fallen 37.2%.
Because the exchange ratio never changes, every move in Marvell's $168.80 stock flows straight into the offer's dollar value. Lumentum's price now sits on two forces outside its control: Marvell's share price and the risk the merger collapses.
What does the 17.2% gap pay for?
The difference between offer value and target price is a merger arbitrage spread (the discount buyers demand for deal risk and waiting time). TIKR reported the deal needs several regulatory approvals, including China's, and isn't expected to close until the first half of 2028. That's a long capital lock-up. Longer timelines and bigger risks produce wider spreads.
There's a cushion, of sorts. Marvell owes Lumentum a $3.2 billion fee if the deal fails on regulatory grounds. That money lands on Lumentum's balance sheet — but shareholders would then hold a standalone stock priced on its own fundamentals, potentially well below offer value.
How strong are the fundamentals underneath?
Strong, on the numbers. Lumentum's fiscal first-quarter 2027 revenue hit $1.26 billion, up 136.5% year over year. December-quarter guidance calls for $1.575 billion to $1.625 billion. Non-GAAP gross margin expanded to 53.2% from 39.4% a year earlier.
The growth engine is near- and co-packaged optics (optical engines placed beside AI processors so data moves as light instead of over copper). Chief Executive Officer Michael Hurlston said in the earnings release: "During the quarter, we secured our second major NPO/CPO win, backed by purchase commitments exceeding $5 billion. Additionally, our OCS demand visibility has expanded significantly in recent months, positioning optical switching to become a multi-billion-dollar annual revenue stream."
The peer comparison favors Lumentum. Coherent (NYSE:COHR) grew fiscal first-quarter revenue 49.9% to $2.37 billion with a 40.6% non-GAAP gross margin; Coherent CEO Jim Anderson said "AI datacenters transition from copper to optical connectivity." Lumentum grows faster and earns a higher gross margin.
What do analysts say?
Bernstein cut its Lumentum price target to $635 from $900, kept its Outperform rating, then later raised the target to $700. That sits above the current $648.06 price but below the offer's implied $759.60. The target effectively prices standalone Lumentum, not the deal.
Who actually benefits from the spread?
A Lumentum holder who waits ends up owning Marvell stock. So the 17.2% gap matters most to investors comfortable holding Marvell for years. If Marvell keeps falling, the payout shrinks with it. Investors who want Lumentum's optics growth without Marvell exposure face a trade-off — closing the deal swaps that exposure away.
Two dates test the spread. First, Marvell's next earnings report, December 1, 2026, after the close. A weak report cuts the offer's value. Second, any regulatory ruling, especially from China. A regulatory setback would likely widen the gap further.
via 247wallst.com (Source)
More from Grace Kim
Show full bio
Market editor covering regulation, policy and their impact on hardware layer of artificial intelligence at Die Signal.
665 articles
Same lot · LOT-362D
- DSG-39697nmMarvell’s $115 Billion Lumentum Deal Draws Two Downgrades
- DSG-680420nmMarvell to Acquire Lumentum in $115 Billion All-Stock Deal
- DSG-298820nmMarvell Stock Needs a 94.9% Gain to Reach $300 by 2029
- DSG-315745nmLumentum Down 40% in a Month Despite Blowout Quarter
- DSG-748765nmArm and Marvell Drop 8% as AI Chip Selloff Deepens